156 related articles for article (PubMed ID: 32495577)
1. [Mechanism of Xuanfei Baidu Tang in treatment of COVID-19 based on network pharmacology].
Wang Y; Li X; Zhang JH; Xue R; Qian JY; Zhang XH; Zhang H; Liu QQ; Fan XH; Cheng YY; Zhang BL
Zhongguo Zhong Yao Za Zhi; 2020 May; 45(10):2249-2256. PubMed ID: 32495577
[TBL] [Abstract][Full Text] [Related]
2. Exploring the mechanism of action of Xuanfei Baidu granule (XFBD) in the treatment of COVID-19 based on molecular docking and molecular dynamics.
Xiong L; Cao J; Yang X; Chen S; Wu M; Wang C; Xu H; Chen Y; Zhang R; Hu X; Chen T; Tang J; Deng Q; Li D; Yang Z; Xiao G; Zhang X
Front Cell Infect Microbiol; 2022; 12():965273. PubMed ID: 36034710
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
[TBL] [Abstract][Full Text] [Related]
4. Xuanfei Baidu decoction attenuates intestinal disorders by modulating NF-κB pathway, regulating T cell immunity and improving intestinal flora.
Ma L; Zhao X; Liu T; Wang Y; Wang J; Kong L; Zhao Q; Chen Y; Chen L; Zhang H
Phytomedicine; 2022 Jul; 101():154100. PubMed ID: 35489324
[TBL] [Abstract][Full Text] [Related]
5. Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MS
Zhang ZJ; Wu WY; Hou JJ; Zhang LL; Li FF; Gao L; Wu XD; Shi JY; Zhang R; Long HL; Lei M; Wu WY; Guo DA; Chen KX; Hofmann LA; Ci ZH
J Integr Med; 2020 May; 18(3):229-241. PubMed ID: 32307268
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology analysis of the therapeutic mechanisms of the traditional Chinese herbal formula Lian Hua Qing Wen in Corona virus disease 2019 (COVID-19), gives fundamental support to the clinical use of LHQW.
Zheng S; Baak JP; Li S; Xiao W; Ren H; Yang H; Gan Y; Wen C
Phytomedicine; 2020 Dec; 79():153336. PubMed ID: 32949888
[TBL] [Abstract][Full Text] [Related]
7. Xuanfei Baidu Decoction protects against macrophages induced inflammation and pulmonary fibrosis via inhibiting IL-6/STAT3 signaling pathway.
Wang Y; Sang X; Shao R; Qin H; Chen X; Xue Z; Li L; Wang Y; Zhu Y; Chang Y; Gao X; Zhang B; Zhang H; Yang J
J Ethnopharmacol; 2022 Jan; 283():114701. PubMed ID: 34606948
[TBL] [Abstract][Full Text] [Related]
8. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
Gao LQ; Xu J; Chen SD
Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717
[TBL] [Abstract][Full Text] [Related]
9. Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacology.
Chen X; Yin YH; Zhang MY; Liu JY; Li R; Qu YQ
Int J Med Sci; 2020; 17(16):2511-2530. PubMed ID: 33029094
[TBL] [Abstract][Full Text] [Related]
10. The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking.
Cai Y; Zeng M; Chen YZ
Ann Palliat Med; 2021 Apr; 10(4):3864-3895. PubMed ID: 33691446
[TBL] [Abstract][Full Text] [Related]
11. Xuanfei Baidu Decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages via PD-1/IL17A pathway.
Wang Y; Wang X; Li Y; Xue Z; Shao R; Li L; Zhu Y; Zhang H; Yang J
Pharmacol Res; 2022 Feb; 176():106083. PubMed ID: 35033647
[TBL] [Abstract][Full Text] [Related]
12. Xuanfei Baidu Formula attenuates LPS-induced acute lung injury by inhibiting the NF-κB signaling pathway.
Zhu Y; Luo L; Zhang M; Song X; Wang P; Zhang H; Zhang J; Liu D
J Ethnopharmacol; 2023 Jan; 301():115833. PubMed ID: 36252879
[TBL] [Abstract][Full Text] [Related]
13. Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach.
Ren X; Shao XX; Li XX; Jia XH; Song T; Zhou WY; Wang P; Li Y; Wang XL; Cui QH; Qiu PJ; Zhao YG; Li XB; Zhang FC; Li ZY; Zhong Y; Wang ZG; Fu XJ
J Ethnopharmacol; 2020 Aug; 258():112932. PubMed ID: 32376368
[TBL] [Abstract][Full Text] [Related]
14. [Clinical observation of Xuanfei Baidu Decoction in treatment of severe coronavirus disease 2019 (COVID-19)].
Li XC; Zhang J; Xia WG; Liu QQ; Wang H; Huang M; Yang FW; Pang B
Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3667-3674. PubMed ID: 35850821
[TBL] [Abstract][Full Text] [Related]
15. [Exploration on scientific connotation of TCM syndromes and recommended prescriptions against COVID-19 based on TCMTP V2.0].
Xu HY; Zhang YQ; Qing YW; Zhao HY; Wang P; Liu F
Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(7):1488-1498. PubMed ID: 32489025
[TBL] [Abstract][Full Text] [Related]
16. Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis.
Wang J; Ge W; Peng X; Yuan L; He S; Fu X
Mol Divers; 2022 Apr; 26(2):1175-1190. PubMed ID: 34105049
[TBL] [Abstract][Full Text] [Related]
17. [A systematic pharmacological investigation of pharmacologically active ingredients in Toujie Quwen granules for treatment of COVID-19].
Ma S; Zhang X; Cen J; Hong G; Hong S; Ju W
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Aug; 40(8):1072-1080. PubMed ID: 32895172
[TBL] [Abstract][Full Text] [Related]
18. Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19).
Huang YF; Bai C; He F; Xie Y; Zhou H
Pharmacol Res; 2020 Aug; 158():104939. PubMed ID: 32445956
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics of 24 major bioactive components in normal and ARDS rats after oral administration of Xuanfei Baidu granules.
Wang X; Zhang J; Luo L; Song X; Wang P; Liu D
J Ethnopharmacol; 2022 Oct; 296():115472. PubMed ID: 35718055
[TBL] [Abstract][Full Text] [Related]
20. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus
Li X; Lin H; Wang Q; Cui L; Luo H; Luo L
Drug Dev Ind Pharm; 2020 Dec; 46(12):1947-1959. PubMed ID: 33054436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
